TRICUSPID REGURGITATION
Clinical trials for TRICUSPID REGURGITATION explained in plain language.
Never miss a new study
Get alerted when new TRICUSPID REGURGITATION trials appear
Sign up with your email to follow new studies for TRICUSPID REGURGITATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart valve repair: which ring works best?
Disease control ENROLLING_BY_INVITATIONThis study compares two types of surgical rings—flexible band and rigid ring—used to repair a leaky tricuspid heart valve (tricuspid regurgitation). About 300 adults with heart valve disease will be enrolled to see which ring leads to better long-term outcomes, such as fewer repe…
Matched conditions: TRICUSPID REGURGITATION
Phase: NA • Sponsor: Nanjing Medical University • Aim: Disease control
Last updated May 26, 2026 09:31 UTC
-
Could a diabetes pill fix two heart problems at once?
Disease control OngoingThis study tests a drug called enavogliflozin (a type of SGLT2 inhibitor) in 541 adults with heart failure and a leaky tricuspid valve. Participants take the drug or a placebo for 18 months. The goal is to see if the drug reduces heart-related deaths, hospital stays, and valve wo…
Matched conditions: TRICUSPID REGURGITATION
Phase: PHASE3 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated May 26, 2026 09:30 UTC
-
New heart valve repair device shows promise for leaky tricuspid patients
Disease control OngoingThis study tests a device called the Edwards Cardioband FIT, designed to repair the tricuspid valve in people with moderate or worse leakage. About 75 participants who still have symptoms despite medication will receive the device. The goal is to see if the procedure is safe and …
Matched conditions: TRICUSPID REGURGITATION
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated May 26, 2026 09:26 UTC
-
New valve device aims to fix leaky heart valve without open surgery
Disease control OngoingThis study tests a new device called the Cardiovalve TR system to replace a leaky tricuspid valve in the heart. About 157 people with moderate to severe leakage and symptoms like shortness of breath are taking part. The goal is to see if the device is safe and can reduce the leak…
Matched conditions: TRICUSPID REGURGITATION
Phase: NA • Sponsor: Cardiovalve Ltd. • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
New stent valve offers hope for rare heart condition patients unable to have surgery
Disease control OngoingThis study tests a new stent valve (TRICENTO) in 15 people with carcinoid heart disease who have a severely leaky tricuspid valve and cannot have open-heart surgery. The goal is to see if the implant can reduce the leak and improve symptoms and quality of life. Participants will …
Matched conditions: TRICUSPID REGURGITATION
Phase: NA • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Heart valve study aims to end treatment guesswork
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at 3,500 adults with severe tricuspid regurgitation (a leaky heart valve) to compare medical therapy, surgery, and a less invasive catheter procedure. The goal is to find which treatment works best and when to use it. Participants are matched by their risk score …
Matched conditions: TRICUSPID REGURGITATION
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Knowledge-focused
Last updated May 26, 2026 09:41 UTC
-
New study tracks heart recovery after tricuspid valve replacement
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at heart failure patients with a severe leaky tricuspid valve who received a new valve through a tube in a blood vessel (transcatheter replacement). It focuses on those who had unstable blood pressure right after the procedure. Researchers want to understand how …
Matched conditions: TRICUSPID REGURGITATION
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated May 18, 2026 12:07 UTC
-
Promising heart valve study pulled before it began
TerminatedThis study planned to test a new device called the Cardiovalve for people with severe tricuspid regurgitation (a leaky heart valve). The goal was to see if the device could safely replace the valve and reduce leakage. However, the study was withdrawn before any participants were …
Matched conditions: TRICUSPID REGURGITATION
Phase: NA • Sponsor: Cardiovalve Ltd.
Last updated May 15, 2026 11:55 UTC